
Profitability, historical returns, and peer comparisons.
According to Kaken Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 6.11%. This represents a change of 305.90% compared to the average of 1.50% of the last 4 quarters.
The mean historical ROE of Kaken Pharmaceutical Co., Ltd. over the last ten years is 10.49%. The current 6.11% ROE has changed -41.77% with respect to the historical average. Over the past ten years (40 quarters), KKPCF's ROE was at its highest in in the September 2024 quarter at 8.12%. The ROE was at its lowest in in the March 2025 quarter at -3.43%.
Average
10.49%
Median
9.49%
Minimum
1.45%
Maximum
21.45%
Discovering the peaks and valleys of Kaken Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 63.66%
Maximum Annual ROE = 21.45%
Minimum Annual Increase = -84.10%
Minimum Annual ROE = 1.45%
| Year | ROE | Change |
|---|---|---|
| 2026 | 1.45% | -84.10% |
| 2025 | 9.14% | 63.66% |
| 2024 | 5.58% | 39.83% |
| 2023 | 3.99% | -42.41% |
| 2022 | 6.93% | -29.54% |
| 2021 | 9.84% | -34.75% |
| 2020 | 15.08% | 2.75% |
| 2019 | 14.67% | -12.25% |
| 2018 | 16.72% | -22.03% |
| 2017 | 21.45% | -8.83% |
The current ROE of Kaken Pharmaceutical Co., Ltd. (KKPCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.39%
5-year avg
5.42%
10-year avg
10.49%
Kaken Pharmaceutical Co., Ltd.’s ROE is less than Kissei Pharmaceutical Co., Ltd. (4.95%), less than KYORIN Holdings, Inc. (0.28%), less than Mochida Pharmaceutical Co., Ltd. (7.68%), less than Zeria Pharmaceutical Co., Ltd. (10.08%), less than Nippon Shinyaku Co., Ltd. (10.14%), less than Ono Pharmaceutical Co., Ltd. (8.69%), less than Sumitomo Pharma Co., Ltd. (13.02%), less than Eisai Co., Ltd. (4.88%), less than Shionogi & Co., Ltd. (14.36%), less than Kyowa Kirin Co., Ltd. (9.54%),
| Company | ROE | Market cap |
|---|---|---|
| 4.95% | $182.40B | |
| 0.28% | $57.22B | |
| 7.68% | $118.19B | |
| 10.08% | $91.16B | |
| 10.14% | $222.63B | |
| 8.69% | $1.16T | |
| 13.02% | $816.22B | |
| 4.88% | $1.49T | |
| 14.36% | $2.66T | |
| 9.54% | $1.33T |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kaken Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kaken Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Kaken Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Kaken Pharmaceutical Co., Ltd. (KKPCF)?
What is the highest ROE for Kaken Pharmaceutical Co., Ltd. (KKPCF)?
What is the 3-year average ROE for Kaken Pharmaceutical Co., Ltd. (KKPCF)?
What is the 5-year average ROE for Kaken Pharmaceutical Co., Ltd. (KKPCF)?
How does the current ROE for Kaken Pharmaceutical Co., Ltd. (KKPCF) compare to its historical average?